5,7-dihydroxytryptamine has been researched along with Constriction, Pathological in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Furukawa, S; Furukawa, Y; Ishikawa, K; Ishikawa, T; Iwanaga, Y; Nakano, M; Okuyama, S; Suenaga, H; Yamagata, H; Yasuda, S; Yoshida, M | 1 |
1 other study(ies) available for 5,7-dihydroxytryptamine and Constriction, Pathological
Article | Year |
---|---|
Imipramine ameliorates pain-related negative emotion via induction of brain-derived neurotrophic factor.
Topics: 5,7-Dihydroxytryptamine; Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Chronic Pain; Constriction, Pathologic; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Emotions; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Gyrus Cinguli; Imipramine; Male; Phosphorylation; Rats, Sprague-Dawley; Reaction Time; RNA, Messenger; Serotonin; Spinal Cord | 2014 |